Get the Stockscreener App
23.40
7.59%
1.65
After Hours:
23.89
0.49
+2.09%
Vtv Therapeutics Inc stock is traded at $23.40, with a volume of 14,223.
It is up +7.59% in the last 24 hours and down -2.90% over the past month.
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.
See More
Previous Close:
$21.75
Open:
$20.23
24h Volume:
14,223
Relative Volume:
3.56
Market Cap:
$61.24M
Revenue:
$17,000
Net Income/Loss:
$-23.87M
P/E Ratio:
-7.50
EPS:
-3.12
Net Cash Flow:
$-22.03M
1W Performance:
+10.43%
1M Performance:
-2.90%
6M Performance:
+4.19%
1Y Performance:
+66.79%
1-Day Range:
$20.23
$25.30
1-Week Range:
$19.80
$25.30
52-Week Range:
$12.62
$26.99
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Name
Vtv Therapeutics Inc
Sector
Industry
Phone
336-841-0300
Address
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
23.40 | 56.92M | 17,000 | -23.87M | -22.03M | -3.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-30-19 | Initiated | H.C. Wainwright | Buy |
| Apr-10-18 | Downgrade | Stifel | Buy → Hold |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-08-18 | Initiated | Northland Capital | Outperform |
| Sep-26-16 | Initiated | H.C. Wainwright | Buy |
| Sep-04-15 | Initiated | Canaccord Genuity | Buy |
| Aug-24-15 | Initiated | Piper Jaffray | Overweight |
| Aug-24-15 | Initiated | Stifel | Buy |
View All
Vtv Therapeutics Inc Stock (VTVT) Latest News
Will vTv Therapeutics Inc. stock deliver consistent dividendsShare Buyback & Free Weekly Watchlist of Top Performers - newser.com
Can vTv Therapeutics Inc. stock sustain market leadershipTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com
How vTv Therapeutics Inc. (5VT0) stock benefits from digital adoptionQuarterly Trade Report & Technical Entry and Exit Tips - newser.com
Will vTv Therapeutics Inc. stock outperform value stocksSell Signal & Daily Oversold Stock Bounce Ideas - newser.com
Custom watchlist performance reports with vTv Therapeutics Inc.2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com
What is the fair value of vTv Therapeutics Inc. stock nowPortfolio Value Summary & Weekly Stock Breakout Alerts - newser.com
Published on: 2025-11-03 02:42:39 - newser.com
Short interest data insights for vTv Therapeutics Inc.2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
Will vTv Therapeutics Inc. stock remain a Wall Street favorite2025 Dividend Review & Fast Momentum Stock Entry Tips - newser.com
Momentum divergence signals in vTv Therapeutics Inc. chartMarket Performance Report & Low Drawdown Momentum Trade Ideas - newser.com
Will vTv Therapeutics Inc. (5VT0) stock justify high valuationJuly 2025 Volume & High Accuracy Swing Entry Alerts - newser.com
Does vTv Therapeutics Inc. show high probability of reboundPortfolio Value Report & Free Accurate Trade Setup Notifications - newser.com
Is vTv Therapeutics Inc. stock dividend yield sustainableJuly 2025 Selloffs & Technical Confirmation Trade Alerts - newser.com
How vTv Therapeutics Inc. stock performs in rising dollar environment2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
Has vTv Therapeutics Inc. found a price floorTrade Risk Assessment & AI Based Buy/Sell Signal Reports - newser.com
Can vTv Therapeutics Inc. (5VT0) stock attract ESG investmentsWatch List & Consistent Growth Equity Picks - newser.com
Published on: 2025-11-02 05:34:24 - newser.com
How vTv Therapeutics Inc. stock compares to growth peersWeekly Investment Report & Entry Point Strategy Guides - newser.com
Why vTv Therapeutics Inc. (5VT0) stock is trending on social mediaJuly 2025 Movers & Weekly High Return Opportunities - newser.com
Published on: 2025-11-02 01:35:19 - newser.com
Can vTv Therapeutics Inc. stock withstand economic slowdownPortfolio Performance Report & High Accuracy Buy Signal Tips - newser.com
Reversal indicators forming on vTv Therapeutics Inc. stockMarket Movement Recap & Daily Oversold Stock Bounce Ideas - newser.com
Is vTv Therapeutics Inc. stock bottoming outSell Signal & Safe Entry Trade Reports - newser.com
Analyzing vTv Therapeutics Inc. with multi timeframe chartsPortfolio Value Summary & Fast Exit and Entry Strategy Plans - newser.com
Risk adjusted return profile for vTv Therapeutics Inc. analyzedJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
Vtv Therapeutics Inc Stock (VTVT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):